Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Autoimmune Disorders01:29

Autoimmune Disorders

672
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
672
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

2.9K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.9K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

521
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
521
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

310
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
310
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

470
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
470

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Editorial: The key role of Mer receptor tyrosine kinase: where inflammation ends and fibrosis begins.

Frontiers in immunology·2023
Same author

Imperfect storm: is interleukin-33 the Achilles heel of COVID-19?

The Lancet. Rheumatology·2020
Same author

Fingolimod reduces salivary infiltrates and increases salivary secretion in a murine Sjögren's model.

Journal of autoimmunity·2020
Same author

Proteins in assemblages formed by phase separation possess properties that promote their transformation to autoantigens: Implications for autoimmunity.

Journal of autoimmunity·2020
Same author

Gas6/TAM Receptors in Systemic Lupus Erythematosus.

Disease markers·2019
Same author

Antibody Cross-Linking of CD14 Activates MerTK and Promotes Human Macrophage Clearance of Apoptotic Neutrophils: the Dual Role of CD14 at the Crossroads Between M1 and M2c Polarization.

Inflammation·2018

相关实验视频

Updated: Sep 11, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.0K

我们能治愈狼吗?

Tessa L Clement1, Philip L Cohen1

  • 1Section of Rheumatology, Lewis Katz School of Medicine at Temple University, 3322 North Broad Street, Suite 201, Philadelphia, PA 19410, USA.

Current opinion in immunology
|August 16, 2025
PubMed
概括
此摘要是机器生成的。

化学抗原受体T细胞 (CAR-T) 疗法在治疗系统性红血狼方面表现有前途,提供潜在的长期缓解. 在T细胞和NK细胞疗法的进步可能为这种自身免疫性疾病提供新的,实用的治疗方法.

更多相关视频

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

17.9K
Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
05:44

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus

Published on: June 10, 2025

220

相关实验视频

Last Updated: Sep 11, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.0K
The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

17.9K
Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
05:44

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus

Published on: June 10, 2025

220

科学领域:

  • 免疫学 免疫学 免疫学
  • 自免疫性疾病 自免疫性疾病
  • 细胞疗法细胞疗法

背景情况:

  • 系统性红斑狼 (SLE) 的发病因子越来越被理解,但目前的治疗方法仍然很大程度上是经验性的,并且往往不令人满意.
  • 以前的向疗法,包括单克隆抗体和干细胞治疗,在治疗SLE方面取得了有限的成功.
  • 耐火性SLE病例在针对B细胞的仿真抗原受体T细胞 (CAR-T) 治疗中看到了意想不到的希望.

研究的目的:

  • 审查CAR-T细胞疗法的新兴潜力,以治疗系统性红斑狼.
  • 讨论SLE治疗细胞疗法的最新进展对SLE管理的影响.
  • 突出系统生物学和单细胞方法在发现SLE新治疗点方面的作用.

主要方法:

  • 审查最近的临床发现和细胞治疗系统性红斑狼的研究.
  • 分析CAR-T细胞治疗在耐火性疾病的小患者队列中的疗效.
  • 探索系统生物学和单细胞技术,以了解SLE的病原性.

主要成果:

  • 在小型患者系列中,CAR-T细胞疗法已经表现出意想不到的前景,导致明显的长期和完全缓解SLE.
  • 在T细胞和自然杀手 (NK) 细胞疗法方面的进展表明,更容易获得的和实用的治疗方法在地平线上.
  • 了解SLE机制的进展正在确定治疗干预的新途径.

结论:

  • 卡尔-T细胞疗法在治疗耐火性系统性红血性狼方面取得了重大进展.
  • 细胞免疫疗法的未来发展,包括基于T细胞和NK细胞的策略,对SLE患者有很大的潜力.
  • 通过系统生物学和单细胞分析,对SLE病变的持续研究可能会产生新的治疗选择,可能导致长期的疾病控制或治愈.